The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGILYSYS INC | COM | 00847J105 | 62,993 | 5,284,648 | SH | SOLE | 5,284,648 | 0 | 0 | ||
| MAXWELL TECHNOLOGIES INC | COM | 577767106 | 9,327 | 1,572,901 | SH | SOLE | 1,572,901 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 7,361 | 272,012 | SH | SOLE | 272,012 | 0 | 0 | ||